Channelopathies in Heart Disease 1st ed. 2018(Cardiac and Vascular Biology) H X, 482 p. 18
目次
Part A: (Dys)function of cardiac ion channels 2. The electrophysiological basis of cardiac conduction and repolarization (include also: Distribution of ion channels in the heart (atrium vs ventricle, conduction system versus working myocardium, Purkinje, transmural distribution)) Jules Hancox (University of Bristol, UK; Jules.Hancox@bristol.ac.uk) 3. Novel insights into ion channel complexity and diversity: relevance for cardiac channelopathies (interacting proteins, subcellular distribution, non-electrogenic effects, electro-mechanical overlap, impact on other organs, etc). Hugues Abriel (Bern, CH) 4. Cardiac sodium channel structure and (dys)function C.A. Remme (Amsterdam, NL) 5. Potassium channels in the heart: structure and (dys)function Nicole Schmitt (Copenhagen, Denmark; nschmitt@sund.ku.dk) 6. Calcium channels and their roles in cardiac electrophysiology Niels Voigt (Göttingen; Germany; niels-voigt@t-online.de) 7. HCN channels and cardiac pacemaking Mirko Baruscotti (Department of Biomolecular Sciences and Biotechnology, University of Milan, Italy; mirko.baruscotti@unimi.it) 8. (Dys)regulation of ionic homeostasis: relevance for cardiac arrhythmias (including ryanodine receptor channelopathies, etc) Luigi Venetucci (Institute of Cardiovascular Sciences, University of Manchester, UK; luigi.venetucci@manchester.ac.uk) Part B: Cardiac channelopathies: clinical and genetic findings 9. Long QT syndrome (including Timothy syndrome), short QT syndrome Lia Crotti (Department of Molecular Medicine, University of Pavia, Pavia, Italy; liacrotti@yahoo.it) 10. Brugada syndrome Koonlawee Nademanee (The Pacific Rim Electrophysiology Research Institute, Los Angeles, USA; wee@pacificrimep.com) 11. Sinus node disease and Lev-Lenègre syndrome-progressive cardiac conduction disease Patrick Schweizer (Heidelberg, Germany; patrick.schweizer@med.uni-heidelberg.de) 12. Catecholaminergic polymorphic ventricular tachycardia Bjorn C. Knollmann (Vanderbilt University School of Medicine, Nashville, USA; bjorn.knollmann@vanderbilt.edu) 13. Idiopathic ventricular fibrillation and early repolarization Pieter Postema (Academic Medical Center, Amsterdam, The Netherlands; p.g.postema@amc.uva.nl) 14. Atrial fibrillation Dierk Thomas (Heidelberg, Germany) 15. Pulmonary arterial hypertension Horst Olschewski (Ludwig Boltzmann Institute for Lung Vascular Research, Medical University of Graz, Austria; horst.olschewski@medunigraz.at) 16. Genetic testing for inheritable cardiac channelopathies Julien Barc (l'institut du thorax, Nantes, France; julien.barc@inserm.fr) Part C: Research into cardiac channelopathies: new avenues 17. Novel imaging techniques in cardiac ion channel research Eli Rothenberg (Department of Biochemistry and Molecular Pharmacology, New York, USA; Eli.Rothenberg@nyumc.org) 18. iPSC-CM: towards personalized therapeutic strategies? Alessandra Moretti (Technical University of Munich, Germany; amoretti@mytum.de) 19. Computational modeling in cardiac channelopathy research Blanca Rodriguez (Department of Computer Science, University of Oxford, Oxford, UK; blanca.rodriguez@cs.ox.ac.uk) 20. Identification of disease modifiers in cardiac channelopathies Elisabeth Lodder/Connie Bezzina (Academic Medical Center, Amsterdam, The Netherlands; e.m.lodder@amc.uva.nl) 21. Transgenic animal models of cardiac channelopathies – benefits and limitations Katja Odening (Universitäts-Herzzentrum Freiburg, Germany; katja.odening@uniklinik-freiburg.de)
カート
カートに商品は入っていません。